Some Women in Their 40s Prefer to Delay Breast Cancer Screening
By Elana Gotkine HealthDay Reporter
MONDAY, July 15, 2024 -- A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according to a study published online July 16 in the Annals of Internal Medicine.
Laura D. Scherer, Ph.D., from the University of Colorado School of Medicine in Aurora, and colleagues examined breast cancer screening preferences among women aged 39 to 49 years in a pre-post survey with a breast cancer screening decision aid (DA) intervention. The analyses included 495 women without a history of breast cancer or known BRCA1/2 gene mutation.
The researchers found that 27.0 percent of participants preferred to delay screening (versus having a mammography at their current age) before viewing the DA compared with 38.5 percent after the DA. The number never wanting mammography did not increase (5.4 percent before the DA versus 4.3 percent after). The risk for breast cancer was lower for participants who preferred to delay screening than those who preferred not to delay. Overall, 37.4 percent of participants reported that the information about overdiagnosis was surprising compared with 27.2 and 22.9 percent for information about false-positive results and screening benefits, respectively.
"These data emphasize the importance of reducing barriers to receiving desired care as well as informing women about mammography benefits, harms, and personal cancer risk estimates as a regular part of screening consultations," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 -- In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
MONDAY, May 19, 2025 -- A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.